Evidence map›Paper›PMID 19020834›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2009

Novel mouse models for understanding HIV-1 pathogenesis.

Aviva Joseph, Kaori Sango, Harris Goldstein

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Aviva JosephDepartment of Microbiology, Albert Einstein College of Medicine, Bronx, NY, USA.
Kaori Sango
Harris Goldstein

Funding

Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
Mechanisms of in vivo protection from HIV infectionR01AI067136 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI GOLDSTEIN, HARRIS · 2007 to 2010
$1.6M
NIAID NIH HHS AI51519NIAID NIH HHS AI67136NIAID NIH HHS P30 AI051519NIAID NIH HHS R01 AI067136
6 · The paper itself

Abstract

Small animal models in which in vivo HIV-1 infection, pathogenesis, and immune responses can be studied would permit both basic research on the biology of the disease, as well as a system to rapidly screen developmental therapeutics and/or vaccines. To date, the most widely-used models have been the severe combined immunodeficient (SCID)-hu (also known as the thy/liv SCID-hu) and the huPBL-SCID mouse models. Recently three new models have emerged, i.e., the intrasplenic huPBL/SPL-SCID model, the NOD/SCID/IL2Rgamma(null) mouse model, and the Rag2(-/-)gamma(c) (-/-) mouse model. Details on the construction, maintenance and HIV-1 infection of these models are discussed.

Indexed as

Disease Models, AnimalAnimalsDNA-Binding ProteinsFemaleHIV-1HIV InfectionsInterleukin Receptor Common gamma SubunitMaleMiceMice, SCIDDNA-Binding ProteinsIl2rg protein, mouseInterleukin Receptor Common gamma SubunitRag2 protein, mouse

Identifiers

PMID19020834
PMCPMC11980812

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.